Confluent and reticulated papillomatosis: response to topical calcipotriol.
Kürkçüoğlu
N
N
Celebi
C R
CR
D000279:Administration, Cutaneous; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009824:Ointments; D010212:Papilloma / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013899:Thoracic Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D009824:Ointments; C055085:calcipotriene; D002117:Calcitriol; D002118:Calcium